egtazic acid has been researched along with Kidney Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belldegrun, A; Bonavida, B; Caliliw, R; Frost, P | 1 |
| Hoepfner, FT; Ivanovic, M; Smith, ND; Thumbikat, P; Veliceasa, D; Volpert, OV | 1 |
2 other study(ies) available for egtazic acid and Kidney Neoplasms
| Article | Year |
|---|---|
Immunosensitization of resistant human tumor cells to cytotoxicity by tumor infiltrating lymphocytes.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Carcinoma; Carcinoma, Renal Cell; Cisplatin; Combined Modality Therapy; Cytotoxicity, Immunologic; Drug Resistance, Neoplasm; Egtazic Acid; Fas Ligand Protein; fas Receptor; Female; Humans; Interleukin-2; Ionomycin; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Lymphocytes, Tumor-Infiltrating; Magnesium Chloride; Male; Membrane Glycoproteins; Ovarian Neoplasms; Perforin; Pore Forming Cytotoxic Proteins; Prostatic Neoplasms; Recombinant Proteins; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 2003 |
Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma.
Topics: Animals; Blotting, Western; Calcium; Carcinoma, Renal Cell; Cell Line; Cell Line, Tumor; Cell Proliferation; Chelating Agents; COP-Coated Vesicles; Corneal Neovascularization; Egtazic Acid; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Kidney Neoplasms; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; Thrombospondin 1; Transfection; TRPC Cation Channels | 2007 |